Standout Papers

The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients 2023 2026 2024117
  1. The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients (2023)
    Mirco Friedrich, Paola Neri et al. Cancer Cell

Immediate Impact

20 standout
Sub-graph 1 of 8

Citing Papers

Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes
2025 Standout
Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
2025 Standout
2 intermediate papers

Works of Michael Kilian being referenced

The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients
2023 Standout
Dysfunctional dendritic cells limit antigen-specific T cell response in glioma
2022

Author Peers

Author Last Decade Papers Cites
Michael Kilian 98 131 54 77 15 224
Veronika Lysenko 130 79 43 75 13 253
S B Ebeling 159 101 34 65 17 266
Brenda Tromp 170 147 20 69 11 257
Benjamin T. Goetz 59 72 44 180 12 290
Miriam Ritz 141 86 13 69 10 250
Corrado Gallo‐Stampino 56 126 11 130 12 247
Joseph Kauer 81 104 19 62 23 188
Jing Christine Ye 55 130 24 83 19 236
Cath Eberlein 28 80 23 160 17 252
Bérengère Vire 102 66 102 92 18 261

All Works

Loading papers...

Rankless by CCL
2026